Ailife Diagnostics, Inc.

Pearland, TX

UEI
Z5GNFKKR29P6
CAGE
96AA6
Primary NAICS
621511 Medical Laboratories
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1920 Country Pl Pkwy Suite 100, Pearland, TX 77584, USA
Website
ailifeus.com
Founded
2018
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 -$1,967
FY2025 $151,800
FY2024 $150,000

Contract awards

Similar vendors

Vendor Location Primary NAICS
Fulgent Genetics, Inc. UEI Y9JMAEN8GRK6 El Monte, CA 621511 Medical Laboratories
Athena Diagnostics, Inc. UEI DM3AM7BCLWL9 Marlborough, MA 621511 Medical Laboratories
Invitae Corporation UEI QCUXDXHHWH29 — 621511 Medical Laboratories
Baylor Miraca Genetics Laboratories LLC UEI HV15NRPPNU25 Houston, TX 621511 Medical Laboratories
Myriad Genetic Laboratories Inc. UEI H7C7T3D6ZSB8 Salt Lake City, UT 621511 Medical Laboratories

About the company

Ailife Diagnostics, Inc. is a woman-owned small business located in Pearland, Texas, specializing in comprehensive genetic testing services for medical diagnostics. Registered in SAM.gov since August 16, 2021, the company provides advanced genetic testing solutions primarily to federal healthcare agencies, with a focus on supporting medical diagnosis, patient management, and reproductive planning. As a for-profit corporate entity, Ailife Diagnostics has positioned itself as a specialized provider of sophisticated genetic testing services across multiple medical specialties.

The company has been awarded several federal contracts primarily with the Department of Veterans Affairs (VA) and the Defense Health Agency, focusing on providing physician-ordered genetic testing services. These contracts include specific genetic testing panels such as kidney gene panel testing, hereditary cancer diagnostic panels, and comprehensive genetic tests covering areas like cardiovascular, neurological, metabolic, immunological, and rare genetic disorders. The contracts are typically not set-aside specific, though some have been designated as Total Small Business Set-Asides. Ailife Diagnostics has demonstrated capabilities in delivering over 200 specific genetic tests, with estimated annual test volumes around 700, including 625 Hereditary Cancer Diagnostic Panels and 75 other diagnostic panels or single gene tests.

The company holds two significant Indefinite Delivery Contracts (IDVs): a $1,121,500.00 IDC with the Michael E. DeBakey VA Medical Center's Pathology & Laboratory Medicine Service, and a $500,000.00 Blanket Purchase Agreement with the Defense Health Agency for genetic testing services at Tripler Army Medical Center in Hawaii. These IDVs cover base years with multiple option periods, with the VA contract running through September 30, 2029, and the Defense Health Agency contract spanning September 8, 2025, to September 7, 2030. The contracts enable Ailife Diagnostics to provide comprehensive genetic testing services, including next-generation sequencing, consultation, and result interpretation across multiple medical specialties, supporting diagnosis and medical management for federal healthcare patients.

Quick answers

Is Ailife Diagnostics, Inc. registered in SAM.gov?

Yes. Ailife Diagnostics, Inc.'s SAM.gov registration is active through March 18, 2027.

What is Ailife Diagnostics, Inc.'s CAGE code?

Ailife Diagnostics, Inc.'s CAGE code is 96AA6, and its Unique Entity ID (UEI) is Z5GNFKKR29P6.

How much has Ailife Diagnostics, Inc. received in federal contracts?

Federal contracts obligated $151,800 to Ailife Diagnostics, Inc. in fiscal year 2025 and $299,833 in fiscal years 2023 through 2027.

What is Ailife Diagnostics, Inc.'s most recent federal award?

Ailife Diagnostics, Inc.'s most recent federal contract award is Medvamc physician genetic testing medically necessary in diagnosis. - 36C25626N0009 ordering year two, from Veterans Integrated Service Network 16 (VHA), on October 1, 2025.

On GovTribe

See Ailife Diagnostics, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe